Parmax Pharma Limited disclosed the voting results of its Extraordinary General Meeting (EGM) held on Thursday, July 2, 2026, at 11:30 am. The disclosure was made to BSE Limited under Regulation 44 of the SEBI Listing Regulations.
The total number of shareholders on the record date (Thursday, June 25, 2026) was 2,381. A total of 30 shareholders were present in the meeting through video conferencing/audio-visual means (14 from Promoter and Promoter Group, 16 from Public). Four resolutions were passed in the meeting.
Resolution 1: Increase in Authorised Share Capital (Ordinary Resolution)
- Description: Increase in authorised share capital of the company and alteration of capital clause of memorandum of association.
- Voting Result: Passed.
- Total Votes Polled: 23,36,153 (62.44% of outstanding 37,41,300 shares)
- Votes in Favour: 23,36,152 (100.00% of votes polled)
- Votes Against: 1
- Promoter & Promoter Group Voting: 11,52,450 shares voted 100% in favor via e-voting.
- Public Non-Institutions Voting: 11,83,703 shares voted via e-voting (45.72% of their 25,88,850 shares), with 11,83,702 in favor and 1 against.
Resolution 2: Adoption of New Articles of Association (Special Resolution)
- Description: Adoption of a new set of articles of association in place of the existing articles.
- Voting Result: Passed.
- Total Votes Polled: 23,36,153 (62.44% of outstanding shares)
- Votes in Favour: 23,36,153 (100.00% of votes polled)
- Votes Against: 0
- Promoter & Promoter Group Voting: 11,52,450 shares voted 100% in favor via e-voting.
- Public Non-Institutions Voting: 11,83,703 shares voted via e-voting (45.72% of their holding), all in favor.
Resolution 3: Preferential Issue of Equity Shares (Special Resolution)
- Description: Issuance of 31,37,586 equity shares on preferential issue on private placement basis to persons belonging to the non-promoter category.
- Voting Result: Passed.
- Total Votes Polled: 23,36,147 (62.44% of outstanding shares)
- Votes in Favour: 23,36,147 (100.00% of votes polled)
- Votes Against: 0
- Promoter & Promoter Group Voting: 11,52,450 shares voted 100% in favor via e-voting.
- Public Non-Institutions Voting: 11,83,697 shares voted via e-voting (45.72% of their holding), with 11,83,697 in favor and 1 against.
Resolution 4: Preferential Issue of Convertible Warrants (Special Resolution)
- Description: Issuance and allotment of 21,45,145 convertible warrants by way of a preferential issue on a private placement basis to a person belonging to the non-promoter category.
- Voting Result: Passed.
- Total Votes Polled: 23,36,153 (62.44% of outstanding shares)
- Votes in Favour: 23,36,153 (100.00% of votes polled)
- Votes Against: 0
- Promoter & Promoter Group Voting: 11,52,450 shares voted 100% in favor via e-voting.
- Public Non-Institutions Voting: 11,83,703 shares voted via e-voting (45.72% of their holding), all in favor.
Scrutinizer's Report
Shreyans Jain of Shreyans Jain & Co. was appointed as the scrutinizer for the EGM voting process. The remote e-voting period commenced on Monday, June 29, 2026, at 9:00 AM IST and concluded on Wednesday, July 1, 2026, at 5:00 PM IST on the platform provided by Purva Sharegistry (India) Private Limited. The votes were unblocked after the conclusion of the EGM in the presence of two witnesses: CS Riddhesh Jain and Mr. Ajit Tibrewal. The scrutinizer confirmed that all four resolutions were passed with the requisite majority.
Additional Information
The company's registered office and factory are located at Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Hadamtala, Tal. Kotda Sangani, Dist. Rajkot-360 311, Gujarat, INDIA. The company manufactures bulk drugs, drug intermediates, and specialty chemicals. The CIN is L24231GJ1994PLC023504.